B.C.-based company, Optimi Health has harvested its first cultivation of psilocybin mushrooms at its Health Canada-licensed facilities in Princeton, B.C., positioning itself as a major player in the burgeoning psychedelic sector. According to Optimi's head cultivator, Todd Henderson, The $14-million venture consists of two 10,000-square-feet facilities with a combined total of 10 growing rooms that can produce approximately 2,000 kilograms of dried psilocybin mushrooms a month.

Pharmadrug is a specialty pharmaceutical company involved in the research, development, and commercialization of controlled substances and all-natural medicines including psychedelics like DMT, cannabis, and naturally occurring drug derivatives.

As an emerging BioPharma and life sciences company, Mydecine is currently researching and developing alternative natural medicines and constructing a drug pipeline for the psychedelic industry. Bought stock offering with Canaccord will increase Mydecine capital by almost 20 million dollars!

Hawaii may soon be the next vacation destination for anyone looking for a psychedelic retreat as a new state measure proposes to legalize psilocybin for therapeutic use after a certified panel reviews the medicinal benefits and science behind psychedelic mushrooms.